A comparison of the EMA, FDA and MHRA guidance on the conduct of clinical trials during the COVID-19 pandemic

By |16-July-2020|Quasar|

Printed in July's 2020 issue of RQA's Quasar Global regulatory authorities acknowledge the impact and increasing pressure that the COVID-19 [...]